Wang Theodore T 4
4 · Bellerophon Therapeutics, Inc. · Filed Jan 4, 2022
Insider Transaction Report
Form 4
Wang Theodore T
Director10% Owner
Transactions
- Award
Stock Options (right to buy)
2021-12-31$3.10/sh+21,828$67,667→ 35,634 totalExercise: $3.10From: 2022-12-31Exp: 2031-12-31→ Common Stock (21,828 underlying)